Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903
Clinical trial NCT05155072 · COMPLETED
Trial details
- NCT number
- NCT05155072
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2020-09-07
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.